Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.

The addition of lithium to the tricyclic antidepressant medication of 11 depressed patients resulted in an increase in the prolactin response to L-tryptophan after both 4 days and 4 weeks of lithium treatment. There was also a significant fall in Hamilton Depression scores. The results suggest that...

Bibliografski detalji
Glavni autori:	Cowen, P, McCance, S, Cohen, P, Julier, D
Format:	Journal article
Jezik:	English
Izdano:	1989

Slični predmeti

Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
od: Cowen, P, i dr.
Izdano: (1991)

Lithium increases 5-HT-mediated prolactin release.
od: McCance, S, i dr.
Izdano: (1989)

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
od: Glue, P, i dr.
Izdano: (1986)

ABNORMAL 5-HT NEUROENDOCRINE FUNCTION IN DEPRESSION
od: Cowen, P
Izdano: (1990)

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment.
od: Cowen, P, i dr.
Izdano: (1987)

Depression resistant to tricyclic antidepressants.
od: Cowen, P
Izdano: (1988)

Depression resistant to tricyclic antidepressants.
od: Cowen, P
Izdano: (1988)

Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.
od: Power, A, i dr.
Izdano: (1992)

Drug treatment of tricyclic resistant depression
od: Chalmers, J, i dr.
Izdano: (1990)

Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
od: Walsh, A, i dr.
Izdano: (1991)

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
od: Nadeem, H, i dr.
Izdano: (2004)

Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses.
od: Best, N, i dr.
Izdano: (1992)

5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
od: Park, S, i dr.
Izdano: (1996)

The effects of a low tryptophan diet on brain 5 -HT metabolism and 5-HT-mediated neuroendocrine responses in the male rat.
od: Franklin, M, i dr.
Izdano: (1995)

Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
od: Friston, K, i dr.
Izdano: (1989)

Slow wave sleep and 5-HT2 receptor sensitivity during maintenance tricyclic antidepressant treatment.
od: Sharpley, A, i dr.
Izdano: (1990)

5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.
od: Cowen, P, i dr.
Izdano: (1994)

Low-dose citalopram as a 5-HT neuroendocrine probe.
od: Attenburrow, M, i dr.
Izdano: (2001)

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressives
od: Bhagwagar, Z, i dr.
Izdano: (2001)

5-HT and depression: is the glass half-full?
od: Sharp, T, i dr.
Izdano: (2011)

Decreased 5-HT-mediated prolactin release in major depression.
od: Anderson, I, i dr.
Izdano: (1992)

Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs.
od: Delva, N, i dr.
Izdano: (1996)

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressed patients.
od: Bhagwagar, Z, i dr.
Izdano: (2002)

Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
od: Williamson, D, i dr.
Izdano: (1995)

Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
od: Gartside, SE, i dr.
Izdano: (1990)

Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
od: Nimgaonkar, V, i dr.
Izdano: (1983)

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
od: Gartside, SE, i dr.
Izdano: (1992)

Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.
od: Cowen, P, i dr.
Izdano: (1986)

Augmentation strategies: 5-HT and beyond
od: Cowen, P
Izdano: (2002)

Decreased sensitivity of 5-HT(1D) receptors in melancholic depression.
od: Whale, R, i dr.
Izdano: (2001)

ENDOCRINOLOGIC RESPONSES TO 5-HT
od: Cowen, P, i dr.
Izdano: (1990)

Sleep and 5-HT2 receptor sensitivity in recovered depressed patients.
od: da Roza Davis, J, i dr.
Izdano: (1992)

Psychopharmacology of 5-HT(1A) receptors.
od: Cowen, P
Izdano: (2000)

PSYCHOTROPIC-DRUGS AND HUMAN 5-HT NEUROENDOCRINOLOGY
od: Cowen, P
Izdano: (1987)

Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.
od: Sharpley, A, i dr.
Izdano: (2001)

Does metergoline selectively attenuate 5-HT mediated prolactin release?
od: Ellis, P, i dr.
Izdano: (1991)

Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission.
od: Cowen, P, i dr.
Izdano: (1997)

A role for 5-HT in the action of antidepressant drugs.
od: Cowen, P
Izdano: (1990)

Neuroendocrine responses to intravenous tryptophan in major depression.
od: Cowen, P, i dr.
Izdano: (1987)

Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?
od: Rabiner, E, i dr.
Izdano: (2004)